Back
Monroe Capital 10K Form
Buy
58
MRCC
Monroe Capital
Last Price:
$8.61
Seasonality Move:
0.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | MRCC/Monroe Capital Quarterly |
2023-11-08 | 10Q | MRCC/Monroe Capital Quarterly |
2023-08-09 | 10Q | MRCC/Monroe Capital Quarterly |
2023-05-10 | 10Q | MRCC/Monroe Capital Quarterly |
2022-11-07 | 10Q | MRCC/Monroe Capital Quarterly |
2022-08-02 | 10Q | MRCC/Monroe Capital Quarterly |
Receive MRCC News And Ratings
See the #1 stock for the next 7 days that we like better than MRCC
MRCC Financial Statistics
Sales & Book Value
Annual Sales: | $5.5M |
---|---|
Cash Flow: | $14.4M |
Price / Cash Flow: | 3.56 |
Annual Sales: | $9.18 |
Price / Book: | 0.94 |
Profitability
EPS (TTM): | 0.60000 |
---|---|
Net Income (TTM): | $13M |
Gross Margin: | $47.6M |
Return on Equity: | 6.43% |
Return on Assets: | 2.5% |
Monroe Capital Earnings Forecast
Key Monroe Capital Financial Ratios
-
The Gross Profit Margin over the past 7 years for MRCC is 439.13%.
-
The Selling, General & Administrative Expenses for MRCC have been equal to 54.53% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 185.70% of Operating Income.
-
The Net Earning history of MRCC is 6.79% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 7 years.
Monroe Capital Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | MRCC |
CUSIP: | 610335 |
Website: | monroebdc.com |
Debt
Debt-to-Equity Ratio: | 1.49 |
---|---|
Current Ratio: | 4.34 |
Quick Ratio: | 4.34 |
Price-to-Earnings
Trailing P/E Ratio: | 430 |
---|---|
Forward P/E Ratio: | 7.86 |
MRCC Technical Analysis vs Fundamental Analysis
Buy
58
Monroe Capital (MRCC)
is a Buy
Is Monroe Capital a Buy or a Sell?
-
Monroe Capital stock is rated a BuyThe current Monroe Capital [MRCC] share price is $8.60. The Score for MRCC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.